Program Description
Presbyopia is an ocular condition that affects visual acuity with gradual onset of blurred vision and inability to see clear details. It is common among individuals older than 40 years, and it can be induced by certain comorbidities, such as diabetes, or use of medications. Current treatment options for presbyopia correction include reading glasses, contact lenses, and a series of surgical techniques. Pharmacists play an active role in providing advice and treatment recommendations for presbyopia and overall eye health. Pharmacologic strategies to correct presbyopia include treatments that address the underlying cause of the condition and alter the composition of the lens and treatments that address symptoms of presbyopia. This activity will review recently approved and emerging pharmaco-refractive agents, with particular focus on their mechanism of action and dynamic pupil modulation. Strategies for pharmacists to identify patients who are at risk for presbyopia and provide education about available treatment options will be discussed.
Target audience: Retail pharmacists
Activity type: Application
Release date: July 29, 2022
Expiration date: July 29, 2023
Estimated time to complete activity: 2 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the burden of illness associated with presbyopia and current gaps in management
- Analyze evidence evaluating current and emerging treatment strategies for presbyopia
- Identify how pharmacists may enhance patient care by intervening in the treatment of eye health
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
